2021
Mental Health and Wealth: Depression, Gender, Poverty, and Parenting
Smith MV, Mazure CM. Mental Health and Wealth: Depression, Gender, Poverty, and Parenting. Annual Review Of Clinical Psychology 2021, 17: 181-205. PMID: 33962537, DOI: 10.1146/annurev-clinpsy-071219-022710.Peer-Reviewed Original ResearchResearch on Posttraumatic Stress Disorder in the Context of the COVID-19 Pandemic: A Review of Methods and Implications in General Population Samples
Husky M, Pietrzak R, Marx B, Mazure C. Research on Posttraumatic Stress Disorder in the Context of the COVID-19 Pandemic: A Review of Methods and Implications in General Population Samples. Chronic Stress 2021, 5: 24705470211051327. PMID: 34765850, PMCID: PMC8576091, DOI: 10.1177/24705470211051327.Peer-Reviewed Original ResearchPosttraumatic stress disorderStress disorderGeneral population sampleMental disordersCOVID-19 pandemicPre-existing mental disordersSevere posttraumatic symptomsPopulation samplePublic health planningDirect trauma exposurePosttraumatic stress disorder (PTSD) symptomsCross-sectional designGeneral populationSnowball sampling strategiesHealth planningTrauma exposureMental healthStatistical ManualDisordersDisorder symptomsInadequate assessmentCriterion ASymptomsPosttraumatic symptomsSelf-report measures
2018
Bidirectionality of Pain Interference and PTSD Symptoms in Military Veterans: Does Injury Status Moderate Effects?
Lee SY, Finkelstein-Fox L, Park CL, Mazure CM, Huedo-Medina TB, Hoff R. Bidirectionality of Pain Interference and PTSD Symptoms in Military Veterans: Does Injury Status Moderate Effects? Pain Medicine 2018, 20: 934-943. PMID: 30016463, PMCID: PMC6497092, DOI: 10.1093/pm/pny133.Peer-Reviewed Original ResearchConceptsPain interferencePTSD symptomsInjury statusDeployment-related injuryCross-sectional studyPost-traumatic stress disorder symptomsPhysical symptom managementSubset of veteransBidirectional relationshipPotential bidirectional relationshipWorse PTSD symptomsOperation New DawnSymptom managementOperation Enduring FreedomVeteran populationFemale veteransSymptomsOperation Iraqi FreedomInjured veteransInjuryPresent longitudinal studyTime pointsPhone interviewsPsychological interventionsDisorder symptoms
2017
Positive and Negative Religious/Spiritual Coping and Combat Exposure as Predictors of Posttraumatic Stress and Perceived Growth in Iraq and Afghanistan Veterans
Park CL, Smith PH, Lee SY, Mazure CM, McKee SA, Hoff R. Positive and Negative Religious/Spiritual Coping and Combat Exposure as Predictors of Posttraumatic Stress and Perceived Growth in Iraq and Afghanistan Veterans. Psychology Of Religion And Spirituality 2017, 9: 13-20. PMID: 28217246, PMCID: PMC5310632, DOI: 10.1037/rel0000086.Peer-Reviewed Original ResearchCombat exposureHigh combat exposurePTSD symptomatologyPosttraumatic stress disorder (PTSD) symptomsHigh PTSD symptomatologyReligious/Spiritual CopingHigher PTSDPosttraumatic stressPosttraumatic growthPTSD symptomsPerceived GrowthDisorder symptomsModerator effectsCopingSpiritual copingAfghanistan veteransPTSDHypothesized directionVeteransSurvey of experiencesSymptomatologyPPTgParticipantsSymptomsPredictors
2016
β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, Australian Imaging B. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. American Journal Of Geriatric Psychiatry 2016, 24: 1191-1195. PMID: 27742526, DOI: 10.1016/j.jagp.2016.08.007.Peer-Reviewed Original ResearchConceptsBDNF genotypeNormal older womenAnxiety symptomsOlder adultsΕ4 carriageOlder womenDepressive symptomsΒ-amyloidGreater severityAustralian Imaging BiomarkersNon-ε4 carriersSeverity of depressiveMet allele carriersSeverity of anxietyGreater depressive symptomsNormal older adultsGreater anxiety symptomsLifestyle StudyΕ4 carriersAPOE genotypeAllele carriersAnalysis of covarianceImaging biomarkersSymptomsDepressive
2014
Gender and Stress in Predicting Depressive Symptoms Following Stroke
Mazure CM, Weinberger AH, Pittman B, Sibon I, Swendsen J. Gender and Stress in Predicting Depressive Symptoms Following Stroke. Cerebrovascular Diseases 2014, 38: 240-246. PMID: 25401293, PMCID: PMC4283501, DOI: 10.1159/000365838.Peer-Reviewed Original ResearchConceptsPost-stroke depressionPost-stroke patientsDepressive symptomsStressful life eventsClinic visitsElectronic momentary assessmentRisk of PSDThree monthsLife eventsStandardized depression scalesRegular clinic visitsSpecific depressive symptomsStandard clinical assessmentPredicting Depressive SymptomsStroke centersAppetite changesProspective studyFunctional outcomeClinical assessmentDepression ScaleDepression assessmentGender differencesAmbulatory monitoringSignificant associationSymptoms
2008
Relationship of perceived risks of smoking cessation to symptoms of withdrawal, craving, and depression during short-term smoking abstinence
Weinberger AH, Krishnan-Sarin S, Mazure CM, McKee SA. Relationship of perceived risks of smoking cessation to symptoms of withdrawal, craving, and depression during short-term smoking abstinence. Addictive Behaviors 2008, 33: 960-963. PMID: 18384974, PMCID: PMC2442160, DOI: 10.1016/j.addbeh.2008.02.013.Peer-Reviewed Original ResearchConceptsShort-term smoking abstinenceShort-term abstinenceSelf-reported experiencesExperienced withdrawal symptomsWithdrawal symptomsBehavioral interventionsSmoking cessationContingency managementCravingRisk beliefsSmoking abstinenceDaily smokersHigh levelsRelationship of riskRisk perceptionNicotine dependenceAbstinenceParticipantsCurrent studySymptoms of withdrawalDepressionBaseline smokingRisk groupsSymptomsRelationship
2007
Depressive Symptoms and Sex Affect Completion Rates and Clinical Outcomes in Cardiac Rehabilitation
Caulin‐Glaser T, Maciejewski PK, Snow R, LaLonde M, Mazure C. Depressive Symptoms and Sex Affect Completion Rates and Clinical Outcomes in Cardiac Rehabilitation. Preventive Cardiology 2007, 10: 15-21. PMID: 17215628, DOI: 10.1111/j.1520-037.2007.05666.x.Peer-Reviewed Original ResearchConceptsBDI-II scoresClinical outcomesDepressive symptomsMultiple logistic regression analysisCardiac rehabilitation completionBody mass indexCoronary heart diseaseLogistic regression analysisSymptoms of depressionLower BDI-II scoresRehabilitation completionExercise capacityCardiac rehabilitationCardiovascular benefitsMass indexCR programCardiovascular healthHeart diseaseLipid profileSymptomsPatientsIndependent effectsWomenRegression analysisCompletion rates
2003
Discontinuation of Antidepressants in Newly Admitted Psychotic Patients
Bowers MB, McKay BG, Mazure CM. Discontinuation of Antidepressants in Newly Admitted Psychotic Patients. Journal Of Neuropsychiatry 2003, 15: 227-230. PMID: 12724466, DOI: 10.1176/jnp.15.2.227.Peer-Reviewed Original Research
2002
Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis
Fortunati F, Mazure C, Preda A, Wahl R, Bowers M. Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis. Journal Of Affective Disorders 2002, 68: 331-334. PMID: 12063160, DOI: 10.1016/s0165-0327(00)00327-x.Peer-Reviewed Original Research
2000
Self-efficacy as a mediator between stressful life events and depressive symptoms
Maciejewski P, Prigerson H, Mazure C. Self-efficacy as a mediator between stressful life events and depressive symptoms. The British Journal Of Psychiatry 2000, 176: 373-378. PMID: 10827887, DOI: 10.1192/bjp.176.4.373.Peer-Reviewed Original Research
1998
Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)
Bremner J, Krystal J, Putnam F, Southwick S, Marmar C, Charney D, Mazure C. Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS). Journal Of Traumatic Stress 1998, 11: 125-136. PMID: 9479681, DOI: 10.1023/a:1024465317902.Peer-Reviewed Original Research
1997
A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome
Rasmusson A, Anderson G, Lynch K, McSwiggan-Hardin M, Scahill L, Mazure C, Goodman W, Price L, Cohen D, Leckman J. A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome. Biological Psychiatry 1997, 41: 117-121. PMID: 8988803, DOI: 10.1016/s0006-3223(96)00380-0.Peer-Reviewed Original Research
1995
Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B. Assessment of extrapyramidal symptoms during acute neuroleptic treatment. The Journal Of Clinical Psychiatry 1995, 56: 94-100. PMID: 7883736.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdultAkathisia, Drug-InducedAntipsychotic AgentsBasal Ganglia DiseasesDystoniaFemaleHumansMaleMiddle AgedParkinson Disease, SecondaryPhysical ExaminationPsychiatric Status Rating ScalesPsychotic DisordersReproducibility of ResultsSeverity of Illness IndexStatistics, NonparametricConceptsExtrapyramidal symptomsDrug regimenAcute treatmentNeuroleptic drugsSide effectsInterrater reliabilityAcute neuroleptic treatmentPatient's drug regimenExtrapyramidal Symptoms ScaleExtrapyramidal side effectsTraditional neuroleptic drugsLow nonsignificant correlationsRatings of symptomsAcute administrationNeuroleptic treatmentAdverse reactionsParkinson's diseasePsychotic symptomsSymptom ScalePsychotic patientsEPS scaleSymptomsClinician ratersCliniciansInterrater agreement
1992
Drug-responsive symptoms during early neuroleptic treatment
Mazure C, Nelson J, Jatlow P, Bowers M. Drug-responsive symptoms during early neuroleptic treatment. Psychiatry Research 1992, 41: 147-154. PMID: 1574541, DOI: 10.1016/0165-1781(92)90106-d.Peer-Reviewed Original ResearchConceptsDrug responseEarly drug responseDays of treatmentIdentification of symptomsNeuroleptic treatmentSerum concentrationsNeuroleptic drugsNeurochemical mechanismsPositive symptomsSymptomsProgressive phaseDrug actionConceptual disorganizationMultiple regression analysisRegression analysisTreatmentPsychosisSeverityHallucinationsResponseDysarthria During ECT Given for Parkinson's Disease and Depression.
Holzer JC, Giakas WJ, Mazure CM, Price BH. Dysarthria During ECT Given for Parkinson's Disease and Depression. Journal Of Ect 1992, 8: 201-203. PMID: 11941170.Peer-Reviewed Original Research
1990
The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects. The Journal Of Clinical Psychiatry 1990, 51: 330-4. PMID: 2199431.Peer-Reviewed Original ResearchMeSH KeywordsAdultAkathisia, Drug-InducedBasal Ganglia DiseasesBenztropineClinical Trials as TopicDose-Response Relationship, DrugDrug Administration ScheduleFemaleHospitalizationHumansMaleParkinson Disease, SecondaryPerphenazinePsychiatric Status Rating ScalesPsychotic DisordersSchizophreniaSchizophrenic PsychologyConceptsExtrapyramidal side effectsSide effectsBrief Psychiatric Rating Scale (BPRS) totalSerious extrapyramidal side effectsIndividual BPRS itemsResolution of psychosisEarly resolutionBlood level monitoringBlood levelsIndividual symptomsTherapeutic thresholdPsychotic symptomsPsychotic inpatientsScale totalDrug efficacyBPRS itemsPerphenazine concentrationSymptomsPsychosisPerphenazineLevel monitoring
1989
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale: II. Validity. JAMA Psychiatry 1989, 46: 1012-1016. PMID: 2510699, DOI: 10.1001/archpsyc.1989.01810110054008.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderYale-Brown Obsessive Compulsive ScaleObsessive Compulsive ScaleYale-Brown scaleScale scoreCompulsive ScaleSecondary depressive symptomsPlacebo-controlled trialCohort of patientsDrug-induced changesObsessive-compulsive disorder symptom severityMeasures of depressionDrug trialsOutcome measuresDisorder symptom severityDepressive symptomsObsessive-compulsive disorder symptomsSymptom severityPatientsBaseline ratingsDisordersDisorder symptomsValid instrumentSymptomsTrials
1986
Reliability and Validity of the Symptoms of Major Depressive Illness
Mazure C, Nelson J, Price L. Reliability and Validity of the Symptoms of Major Depressive Illness. JAMA Psychiatry 1986, 43: 451-456. PMID: 3964024, DOI: 10.1001/archpsyc.1986.01800050053006.Peer-Reviewed Original ResearchConceptsMajor depressive illnessDepressive illnessPatient-reported symptomsConcurrent validityMajor depressionPatient reportsIndividual symptomsSymptomsConsecutive studiesObserved dysfunctionMost signsInterrater reliabilityDysfunctionIllnessSemistructured interviewsSubjective reportsValid indicatorObservable symptomsReportDaily behaviorClinicians
1985
Ruminative thinking A distinctive sign of melancholia
Nelson J, Mazure C. Ruminative thinking A distinctive sign of melancholia. Journal Of Affective Disorders 1985, 9: 41-46. PMID: 3160746, DOI: 10.1016/0165-0327(85)90008-4.Peer-Reviewed Original Research